BB
TTPH

BB Biotech’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

BB Biotech’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-18,310
Closed -$3.67M – 30
2015
Q4 		$3.67M Sell
18,310
-55,796
-75% -$11.1M 0.1% 30
2015
Q3 		$11.1M Sell
74,106
-1,250
-2% -$917K 0.35% 27
2015
Q2 		$71.5M Buy
75,356
+1,500
+2% +$1.23M 1.94% 16
2015
Q1 		$54.1M Buy
73,856
+8,750
+13% +$6.57M 1.61% 19
2014
Q4 		$51.7M Buy
+65,106
New +$35M 1.67% 19

Other funds holding TTPH

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BB Biotech's TTPH Position: Q1 2016 in Review

BB Biotech sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q1 2016, closing a stake of 18,310 shares — an estimated $3.67M sold.

BB Biotech first reported a position in TTPH in Q4 2014 and held it in 5 quarters. The position peaked at $71.5M in Q2 2015. 101 funds tracked by Wall St. Rank hold TTPH as of Q1 2016.

  • BB Biotech reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
  • BB Biotech sold 18,310 Tetraphase Pharmaceuticals, Inc. shares in Q1 2016, an estimated $3.67M.
  • BB Biotech first reported a position in Tetraphase Pharmaceuticals, Inc. in Q4 2014 and held it in 5 quarters.
  • BB Biotech's Tetraphase Pharmaceuticals, Inc. position peaked at $71.5M in Q2 2015.
  • 101 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q1 2016.

Based on BB Biotech's 13F filing for Q1 2016, filed 12 May 2016.